A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report.
The prognosis of malignant pleural tumors remains extremely unfavorable. The aim of this study is to evaluate the combination of intrathoracic intrapleural chemotherapy and intrapleural hyperthermia (ITCH) in these diseases. Under anesthesia, 5 men were studied. After pleurectomy for mesothelioma (3/5) or adenocarcinoma (2/5), ITCH is carried out for over 60 min, either with mitomycin C (4/5) or cisplatin (1/5). No pre- or postoperative death occurred. The maximal pleural temperature is 42.6 degrees C. The blood level of mitomycin C never reached the systemic toxic level. All the patients were discharged from the surgical ward, 3 are still alive 15 months later. Therefore, ITCH appears to be a safe and reliable therapy.
Carry
P Y
PY
Department of Anaesthesia, Centre Hospitalier Lyon-Sud, France.
Brachet
A
A
Gilly
F N
FN
Sayag
A C
AC
Petit
P Y
PY
Rochette
C
C
Mulsant
P
P
Guibert
B
B
Braillon
G
G
Banssillon
V
V
D000230:Adenocarcinoma / Q000628:therapy*; D000328:Adult; D000368:Aged; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008654:Mesothelioma / Q000628:therapy*; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use*; D010997:Pleural Neoplasms / Q000628:therapy*; D013696:Temperature
D008937:Mitomycins; D002945:Cisplatin